Latest News about ACLX
Recent news which mentions ACLX
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
From Benzinga
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
From InvestorPlace
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 12, 2023
From Benzinga
From Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
From InvestorPlace
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
From Benzinga
Why Is Blood Cancer Focused Arcellx Stock Trading Higher Today?
November 02, 2023
Tickers
ACLX
From Benzinga
From Benzinga
7 Biotech Stocks to Get In Now Before Investors Catch On
October 23, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
From Benzinga
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
From InvestorPlace
FDA Gives Green Signal To Arcellx's Stopped Blood Cancer Study
August 15, 2023
Tickers
ACLX
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
From Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 20, 2023
From Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
June 20, 2023
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.